| Předmět: |
|
| Zdroj: |
Immunotherapy Weekly; 1/12/2024, p933-933, 1p |
| Abstrakt: |
A new report discusses research findings on head and neck cancer from the Canberra Hospital. The report highlights the challenges of treating advanced head and neck cancer and the limitations of antibody-based immunotherapies. The researchers propose exploring small molecule immunotherapies and their potential to improve outcomes in difficult-to-access cases. The report also mentions the concept of targeted, sustained release immunotherapies using electrospun scaffolds. For more information, readers can refer to the journal article "Personalised Medicine and the Potential Role of Electrospinning for Targeted Immunotherapeutics in Head and Neck Cancer" published in Nanomaterials. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
